4A3302).
Introduction
Thus far, 16 different types of collagen, referred to as Types I-XVI, and more than 20 corresponding genes have been identified in humans (1). Types I and 111 collagen distribute ubiquitously in the interstitium of many organs as fibrillar collagens. Type 111 collagen has been called "fetal collagen" owing to its relative abundance in fetal tissues. The ratio of the content of collagen Types I and 111 varies with the type of tissue and with the stage of the developmental or pathological process (2-4). Collagen is synthesized by cells as the precursor molecule, procollagen, which contains extension propeptides at the amino and carboxyl ends of the collagen a-chain. Procollagen processing is necessary for extracellular fibril formation and matrix assembly (5) (6) (7) (8) (9) (10) .
The placenta provides a unique model for studying collagen synthesis because of the presence of many types of collagen and their dynamic regulation, including synthesis and degradation during placental formation. The expression and distribution of collagen Types I, 111, IV, V, and VI are observed in human placental tissue (11) (12) (13) , but human collagen analysis in the early stages of placentation is essentially unknown owing to limited availability of the tissue. The histological structure of the placenta in both human and rat is essentially classified as hemochorial type (14J5).
Although several histological and ultrastructural studies have reported that collagenous fibers are present in the space adjacent to the implantation site and in the intercellular space of the decidua in the chorioallantoic placenta of pregnant rat (16) (17) (18) , the characterization of collagen types during placentation has not yet been fully examined. Analysis of developmentally regulated collagen synthesis during placentation in the rat is important for understanding the function of collagen in the fetomaternal relationship.
In the present study, we produced and characterized specific antibodies to rat procollagen Types I and I11 (Pro I and Pro 111) and also performed biochemical analysis and immunohistochemical localizations of major fibrillar Pro I and Pro I11 during placental formation in pregnant rat. 
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Materials and Methods
Pro I and Pro I11 polyclonal antibodies was tested by ELlSA as previously reported (23).
Preparation and Characterization of Anti-Rat Pro I
Electrophoretic Transfer and Immunoblotting (western Blot). Immu-
and Pro III AntibodieJ
Extraction and Purification of Pro I and Pro III. Pro I and Pro I11 were purified from 4-week-old Wistar rat skin according to a method previously described (19). Bridly. after neutral salt extraction the collagenous proteins were separated from acidic macromolecules by passage through a DEAE-ccllulox column. Separation of Pro 111 from Pro I was performed by a DEAE-cellulose column equilibrated with 20 mM NaCI. 2 M urea, 30 mM Zis-HCI buffer, protease inhibitors (10 mM EIYLA, 1 mM phcnylmethane sulfonyl fluoride. and 1 mM N-ethylmaleimide) (pH 7.5). and by elution with a linear salt gradient from 20-200 mM NaCl over a total volume of 500 ml noblotting was performed as previously reported (24). The sample containing Pro I or Pro I11 was separated on 7.5% SDS-PAGE in the presence of 2-mercaptoethanol and was transferred electrophoretically to a nitrocellulose membrane (Schleicher & Schucll; Dassel. Germany). The transferred sample was allowed to react with affinity-purified anti-Pro I or anti-Pro 111 antibodies. followed by incubation with peroxidase-conjugated goat antirabbit IgG. A color reaction was then performed with 4-chloro-1-naphthol (Polysciences; Warrington, PA). After transferring the antigen to a nitrocellulose membrane, the SDS-PAGE slab gel was also stained with Coomassic Brilliant Blue R 250 (Merck; Darmstadt. Germany). In addition, collagen types I. 111. IV. and V were also purified by salt fractionation (20.21).
Biochemical Analysis of Synthesized Collagen Types I and III
Pepsin Digestion of the Fraction IncIuding Pro III. For SDS-PAGE and immunoblotting. some samples containing Pro 111 were digested with 0.2% pepsin in 0.01 N HCI solution at 25°C for 5 hr.
Preparation of Anti-Pro I and -Pro III Antibodies and ELISA. Female New Zealand albino rabbits weighing 2.0-3.0 kg were immunized with the fractions containing Pro I or Pro I11 and their intermediate peptides. extracted from rat skin. One mg of each fraction emulsified in an equal volume of complete Freund's adjuvant (Difco; Detroit, MI) was injected SC. Booster injections (500 pg) were given with incomplete Freund's adjuvant subcutaneously at 2 and 4 weeks after the first injection. Rabbit antiserum against rat Pro I or Pro I11 was purified by passage through a rat fibronectin (IN)-, collagen types I-, III-, IV-. and V-conjugated Sepharose 4B affinity column (Pharmacia; Uppsala. Sweden). Rat FN was purified from rat plasma as previously described (22). The specificity of the anti-rat Preparation ofRadioIatxIed CoUagen from Pregnant at Uteri. [I4c]-Glycine (100 pCi/rat; 90 pCi/mmol) (ICN Biomedicals; Irvine, CA) was injected IP into 10 pregnant Wistar rats on the Days 8 and 12 of gestation. After 24 hr, the entire uterus. including placentas and embryos. was resecred from each rat under ether anesthesia. After removal of the parametrial fat tissue. the embryos and outer muscle layer of the uteri, the placentas, and the surrounding inner myometrium were minced and homogenized with a Polytron homogenizer in 300 ml of extracting buffer (pH 7.4) at 4'C. The buffer consisted of 150 mM NaCI, 50 mM Tris-HCI buffer, and protease inhibitors. All subsequent procedures were carried out at 4°C. After overnight extraction in this buffer, the precipitate was collected by centrifugation (50,000 x g for 60 min) and extracted with a buffer containing 1 M NaCl for 24 hr. After clarification by centrifugation (70,000 x g for 60 min). the 150 mM Tris-HCI buffer extract. a 1 M NaCl extract, and the neutral insoluble precipitate were all dialyzed against a large volume of distilled water and lyophilized. The lyophilized neutral insoluble precipitate was digested with pepsin (Sigma; St Louis, MO) at a 120 ratio between the weight of enzyme and dry weight of neutral insoluble precipifate in 0.5 M acetic acid for 48 ht at 4' C. To stop pepsin digestion, the pH of the digested sample solution was adjusted to neutral with 2 M NaOH. Sample solutions were dt-fractionated at 0.7 M and 1.2 M NaCl in 0.5 M acetic acid. The precipitates and pepsin-insoluble midua were dialyzed against distilled water and lyophilized, and were stored at -2O' C. for 5 min and then run on a 7.5% SDS-polyacrylamide gel. SDS-PAGE slab gels were stained with Coomassie Brilliant Blue R 250. For fluorography. some of these gels were washed with distilled water and then soaked in Enlightning (Dupont; Boston, MA) for 30 min and dried under vacuum in a slab gel drier. The gels were exposed to prdlashed Kodak X-Omat f i l m for 30 days at -80°C.
Tissue Preparation and HiJtologicd, Immunohistochemical Studies of
PTegnant &t uteri tissues, were collected on Days 8,9.5, 13, and 20 of gestation (Day 0 being the day of a sperm-positive vaginal smear). For histological identification of the specificities of anti-Pro I and anti-Pro 111 antibodies, some whole 20-day fetuses were also examined. At least three pregnant Wistar rats on each day of gestation were anesthetized with ether and perfused via the aorta by infusion ofO.01 M PBS, pH 7.4, followed by fixation with a periodate-lysine-paraformaldehyde (PLP) solution. Dissected uteri, including implantation sites or fetomaternal placental tissues, were sliced transversely and then retained in PLP fmtive for 6-8 hr at 4'C. After washing in PBS, the tissue blocks were dehydrated in a graded series of ethanol and embedded in paraffin. Transverse and serial sections, including implantation areas or fetomatemal placend tissues, were cut at 5 pm. For immunohistochemical study, depdinized sections were treated with 1% H202 in methanol for 30 min to minimize endogenous peroxidase activity, and washed in PBS. Sections were covered with 5 % normal goat serum in PBS for 30 min, then covered with the primary antibodies and incubated overnight at 4%. Affinity-purified anti-Pro I and anti-Pro 111 antibodies were diluted 1:300 and 1:100, respectively. Jmmunoreaction was performed using the Vectastain peroxidase rabbit ABC kit (Vector; Burlingame, CA). Sections were washed in PBS and the antigenic sites were demonstrated by reacting the sections with a mixture of 0.05 % 3,3'-diaminobenzidine tetrahydrochloride (Dojin Chemical; Tokyo, Japan) in 0.05 M Tris-HCI buffer, pH 7.6. and 0.01% H202 for 7 min. Nuclei were stained with methyl green, dehydrated in ethanol, cleared in xylene, and mounted in Permount (Fisher Scientific; Fair Lawn, NJ). The consecutive sections were also stained with hematoxylin-eosin for histological characterization.
Results

Characterization of Anti-rat Pro I and Pro III Anti&odies
On direct ELISA, the affinity-purified anti-Pro I antibody specifically reacted with a fraction containing Pro I but not with collagen Types I, IV, 111, V, or a fraction containing Pro 111, FN, or laminin.
On the other hand, anti-Pro 111 antibody specifically reacted with a fraction containing Pro I11 but not with collagen Types I, 111, IV, V, Pro I, and FN or laminin (data not shown). By immunoblot analysis of a fraction containing Pro I, collagen Type I, and intermediate collagen Type I with C-or N-propeptide, anti-Pro I antibody recognized both a band of prod (1) (Figure 2, Lanes 1 and 3) . After pepsin digestion of the Pro 111 fraction, this antibody did not crossreact with a band of al(II1) (Figure 2, Lanes 2 and 4 ). In addition, each Pro I and Pro 111 antibody revealed no crossreactivity for collagen Types I, 111, IV, V, FN, or laminin (data not shown).
Biochemical Analysis of Synthesized Collagen %pes I and III in Pregnant Rat Uteri
In SDS-PAGE of pepsin-digested fractions containing [ 14C]glycine-incorporated collagen from '+day and 13-day (Figure 3 , Lanes 1 and 2) pregnant rat uteri, a thick a-band, including al (1) and al(II1) chains, and a thin a2(I)-band were detected. These bands labeled with [ 14C]-glycine were detected in fluorography ( Figure  3, Lanes 3 and 4) . The labeling intensities of the a-bands were higher than the a2(I)-band.
Immunohistochemical Emmination of the Spectpczties of Anti-Pro I and Pro III Antibodies in the Rib Bone of a 20-day-old Rat Fetus
To confirm the specificities of anti-Pro I and anti-Pro I11 antibodies, we examined immunohistuchemically serial sections of a whole 20-day fetus. Differential immunolocalization of these antibodies was observed in the ribs. Lining osteoblasts along bone trabeculae and cortical bone strongly reacted with anti-Pro I antibody. Bone matrix and periosteal interstitium were weakly stained with this antibody ( Figure 4A ). Conversely, strong immunoreactivity with anti-Pro 111 antibody was observed in periosteal interstitium and sinusoidal capillary walls but not in osteoblasts ( Figure 4B ).
Comparison of Pro I and Pro III Immunolocalization in Transverse Serial Sections of Pregnant Rat Uteri
Day 8 of Gestation (Early Stage). The basal decidua and the decidual area adjacent to the implantation site of the fetus were more intensely stained with Pro I antibody ( Figure 5A ) than with Pro 111 antibody ( Figure SB) . Intracytoplasmic immunoreactive products were detected in small decidual cells in the basal decidua and in myometrial fibroblasts with both antibodies at high-power viewing (data not shown). Although staining intensities with both antibodies were dlfferent in the decidual zone, extracellular immunostaining patterns were essentially reticular and fibrillar ( Figures  5C-5F ). Large mature decidual cells around the implantation site were not stained with either antibody (Figures SE and 5F ).
Day 9.5 of Gestation. At this stage, fetal tissues, including the yolk sac and ectoplacental cone, had developed and the maternal basal decidua and myometrium of the mesometrial side were hyperplastic. The basal decidua, the decidua adjacent to the cytotrophoblastic giant cell layer surrounding the fetal tissues, and the inner muscle layer showed stronger immunoreactivity for Pro I ( Figure  6A ) than for Pro 111 ( Figure 6B ). Interestingly, large trophoblastic cells invading the matemal central artery were strongly stained with Pro I11 antibody ( Figures 6B and 6D) but not with Pro I antibody ( Figures 6A and 6C) . These Pro 111-producing traphoblastic cells exhibited a large nucleus and a peculiar nucleolus by hematoxylin-eosin staining (data not shown). Conversely, the outer small fibroblastic cells around the artery adjacent to the decidua were stained with Pro I antibody ( Figure 6C ).
Day 13 of Gestation (hiid-stage). At this stage, the fetomaternal vascular system had developed in the labyrinth. The cytotrophoblastic cell layer and fetal blood capillaries in the labyrinth were formed by proliferation of the fetal tissues from the ectoplacental cone and allantoic mesoderm, and the maternal decidua containing the maternal central artery was compressed by the growth of the labyrinth and fetus. Fetal mesenchyme and fetal blood capillaries in the labyrinth showed co-localized immunostaining pat- 111 (B,D) are localized in the fetal mesenchyme (f) and the walls of large blood vessels (v); they are localized discontinuously in the subendothelial stroma of fetal small blood capillaries in B and D. Note the relativelyweak immune staining of Pro I in A and C. Bars: A,B = 0.25 mm; C,D = 24 pm. terns with both antibodies (Figures 7A and 7B) . The cytouophoblastic cell layer, giant cell layer, and maternal decidua, including the central artery, were not stained with Pro I antibody ( Figures  7A and 7C ). However, fibrillar and intracytoplasmic immunoreactive products of Pro 111 were observed in the cytouophoblastic cell layer and in the wall of the maternal central artery in the maternal decidua ( Figures 7B and 7D) . Hyperplastic myometrium containing developed large blood vessels continued to be immunoreactive to Pro 111 antibody (Figure 7B) , and immunostaining with Pro I antibody disappeared around these blood vessels and the inner interstitium of the myometrium ( Figure 7A ).
Day 20 of Gestation (Late Stage). By Day 20, the labyrinth of the placenta was remarkably developed in association with the peak of f e d growth. The fetal allantoic mesenchyme and fetal blood capillaries in the labyrinth were more intensely stained with Pro 111 antibody ( Figure 8B ) than with Pro I antibody ( Figure 8A) . The subendothelial spaces of large fetal blood vessels were linearly stained with both Pro I ( Figure 8C ) and Pro 111 antibodies ( Figure 8D ), and the linear staining pattems of small fetal blood capillaries were weak and interrupted with both antibodies (Figures 8C and 8D ).
Discussion
The developing placenta is a unique model for studying the biological functions of extracellular matrices (ECM), although there are limitations owing to its transience and complexity. Recently, several studies on laminin, Type IV collagen, and fibronectin of the basement membrane of the placenta in humans and in several other species have been reported (18, 27, 28) . On the other hand, it is well known that major interstitial collagens, Types I and 111, are synthesized and localized in the human decidua during the first trimester (11) and are observed in human full-term placental villi (13). However, the sequential characterization of collagen types during placentation has not yet been reported both immunohistochemically and biochemically in humans and rats.
In the present study, biochemical analysis of newly formed [ 14C]-glycine-labeled collagen from pregnant rat uteri on Days 9 and 13 of gestation qualitatively confirmed that both collagen Types I and 111 were synthesized actively at both stages (Figure 3 ). Both anti-Pro I and anti-Pro I11 antibodies, which we prepared, reacted not only with each proa-band but also with each upper half of the intermediate bands by immunoblotting assay (Figures 1 and   2 At the early stage involving decidualization ofthe endometrium, a previous immunohistochemical and biochemical report showed that collagen Types I, 111, IV, and V are synthesized in the human decidua (11) . Although differences in immunohistochemical staining intensity are not always related to the amount of antigen, the immunohistochemical findings described here suggested that the medium-sized decidualizing cells most actively synthesize both collagen Types I and 111 in the basal decidua. These results may answer the question of which types of decidual cells (undifferentiated stromal cells or mature large decidual cells) are related to collagen synthesis in the culture system (11) . Mature large decidual cells around the implantation site were not stained intracellularly with either anti-Pro I or anti-Pro 111 antibodies. In this stage, Type I collagen was predominant in the decidualized area in comparison with Type 111. Several fragmented thick fibrils, which were stained with anti-Pro 111 antibody in the basal decidua, may correspond to the cross-banded thick collagen fibrils with diameter up to 300 nm that have been described in the mouse decidua (29). The thick and fibrillar ECM, including several types of collagen around fetal tissues, may be associated with the support of the fetus and blood circulating channels, and with the preparation of microenvironments involved in the trophoblastic invasion in the decidua.
At the mid-stage of gestation, when the fetomaternal vascular system in the labyrinth has already been established, co-localization of both Pro I and Pro 111 was seen in the fetal allantoic mesoderm, some fetal blood capillaries in the labyrinth, and in the maternal myometrium, with the exception ofthe enlarged myomeuial stroma. The decreased immunoreactivity to both antibodies observed in the decidual zone may be related to the gradual compression of the decidual zone during the growth of the labyrinth and fetus. The enlarged myometrial stroma situated just below the mesometro-uterine junction is composed of highly coiled and anastomosing small arteries, described as a "vascular knot" in the hamster (30). During the development of rat uteri from early (9.5 days) to mid-gestation (13 days), we noted the transformation of the matemal cenual artery into the uteroplacental artery, whose wall was replaced by invading trophoblastic cells with a large nucleus and a peculiar nucleolus, which have been seen physiologically in primates and other mammals, including rodents (14, 15, 30, 31) . This modification may be important for ensuring an adequate blood supply to the developing placenta. In the human, insufficient modification of the spiral arteries, complicated by hypertension, has been associated with retarded fetal growth and miscarriage (32). Interestingly, in this experiment, intracytoplasmic immunoreactive products of Pro 111 were clearly identified in these large trophoblastic cells, which were replacing the wall of the developing matemal central artery. In addition, fibrillar depositions of Pro I11 were seen in the cytotrophoblastic cell layer. The transient and restricted expression of Type 111 collagen in the maternal central artery and cytotrophoblastic cell layer may be thought of as a biological phenotype of the invading trophoblasts.
At the late stage of gestation, the biological function of the increased immunoreactivity of Pro I11 in the labyrinth is unclear. Among the several types of collagen existing in the vessel wall, Type 111 collagen is a strong aggregant of platelets (33). From mid-to late stage, the increased immunostaining of Pro I11 in the labyrinth, the cytotrophoblastic cell layer, and the maternal central artery may be related to the rapid growth of the fetomatemal circulation in association with the proliferation and migration of trophoblastic and endothelial cells. The aggregative function of Pro 111 may be associated with preparing a microenvironment for parturition.
It has been well confirmed that the procollagen peptides are cleaved during their processing and secretion (5, 6, (8) (9) (10) . The immunostaining intensity of Pro I distinctly decreased in the enlarged myometrium containing developed large blood vessels on Day 13 of gestation and in the labyrinth on Day 20, whereas the immunestaining intensity of Pro I11 was the same at both stages. Further study is needed to determine whether or not these differential immunostaining pattems of Pro I and Pro I11 relate to spatiotemporal
